Enlivex Therapeutics - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeEnlivex Therapeutics
Enlivex Therapeutics logo

Enlivex Therapeutics

0 followers

ENLV

Performance

About Enlivex Therapeutics

Enlivex Therapeutics is a biotechnology company that harnesses the natural healing power of macrophages to treat inflammatory diseases. Its proprietary off-the-shelf cell therapy platform, Allocetra, has the potential to redefine the way inflammatory diseases are treated.

Recent News

Recent Deals

Key Team Members

Shachar Shlosberger

CFO

Sigal Arad

Director of Human Resources

Einat Galamidi, M.D.

VP Medical

Dr. Roger Pomerantz, M.D.

Vice Chairman

Shai Novik

Executive Chairman

Key Facts

HQ Location

Ness Ziona, Israel

Founded

2005

Employees

11 - 50

Status

Public

Website

https://enlivex.com